Horizon Alert
Summary of the vulnerability and why it matters
A deserialization vulnerability has been identified in ThemeREX Group's IPharm product, potentially allowing for object injection. This means an attacker could manipulate data to execute malicious code, impacting the integrity and availability of systems using the affected technology. The primary concern is to confirm if this specific technology is in use within our environment and to what extent.
- An attacker could inject malicious code.
- It impacts a public-facing web component.
- Confirm relevance and exposure to our systems.
Attack Path
How an attacker could exploit the issue
An attacker could exploit this vulnerability by sending specially crafted data over the network to a vulnerable instance of the IPharm system. This data would be processed by the system's deserialization component, leading to the injection of malicious objects. Successful exploitation could allow an attacker to execute arbitrary code and compromise the integrity and availability of the system.
- No authentication or special access is required.
- Specially crafted data is sent to the deserialization function.
- Allows for code execution and system compromise.
Live Threat
Current exploitation, exposure, and threat context
This vulnerability could allow an unauthenticated attacker to inject arbitrary PHP objects into the application when specific conditions are met. This could lead to the execution of unintended code or manipulation of application logic, potentially impacting the confidentiality, integrity, and availability of the affected system.
- Arbitrary PHP objects could be injected.
- Exposure may occur via network requests.
- Code execution or data manipulation could result.
Operational Fix
Recommended remediation, mitigation, and detection steps
To address this deserialization vulnerability, the application owner or the platform team responsible for the IPharm instance should initiate the first step by identifying all deployed IPharm instances. Subsequently, confirm the business criticality and network exposure of these instances to prioritize remediation efforts. Coordinating with the vendor for any available patches or workarounds is also crucial.
- Application owners should lead remediation.
- Verify IPharm instance exposure and criticality.
- Plan vendor coordination for fixes.
